🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
371 medicines starting with “V”
MedicineActive substanceLicence holderStatus
Vaborem 1 g/1 g powder for concentrate for solution for infusion
EU/1/18/1334/001
VABORBACTAM, Meropenem, Meropenem Trihydrate Menarini International Operations Luxembourg S.A.
Vabysmo 120 mg/mL solution for injection
EU/1/22/1683/001
Faricimab Roche Registration GmbH
VAFSEO 150 mg Film-coated tablet
EU/1/23/1725/001-002
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
VAFSEO 300 mg Film-coated tablet
EU/1/23/1725/003-004
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
VAFSEO 450 mg Film-coated tablet
EU/1/23/1725/005-006
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
Vagifem 10 micrograms vaginal tablets
PA0218/030/002
Estradiol Novo Nordisk A/S Marketed
Vagirux 10 microgram vaginal tablets
PA1330/028/001
Estradiol Gedeon Richter Plc Marketed
Valaciclovir 500 mg film-coated tablets
PA2315/102/001
Valaciclovir Accord Healthcare Ireland Ltd. Not marketed
Valaciclovir Bluefish 500 mg film-coated tablets
PA1436/005/001
Valaciclovir Bluefish Pharmaceuticals AB Marketed
Valaciclovir Teva 500 mg Film-coated Tablets
PA0749/036/001
Valaciclovir Teva Pharma B.V. Marketed
Valcyte 450 mg film-coated tablets
PA2239/023/001
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Valcyte 50 mg/ml powder for oral solution
PA2239/023/002
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Valdoxan 25 mg film-coated tablets
EU/1/08/499/1-8
Agomelatine Les Laboratoires Servier
Valdrian hard capsules
TR25313/001/001
HUK Europe Limited Not marketed
Valerian Complex Stress Relief Oral Drops
TR2309/020/001
A.Vogel Ireland Limited Marketed
Valganciclovir Accord 450 mg film-coated tablets
PA2315/179/001
Valganciclovir hydrochloride Accord Healthcare Ireland Ltd. Marketed
Valoid 50 mg Tablets
PA1142/001/002
CYCLIZINE HYDROCHLORIDE Amdipharm Limited Marketed
Valoid 50 mg/ml Solution for Injection
PA1142/001/001
Cyclizine Amdipharm Limited Marketed
Valotix 500mg film-coated tablets
PA0711/173/001
Valaciclovir hydrochloride Rowex Limited, Marketed
Valsartan Krka 160 mg film-coated tablets
PA1347/010/008
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan Krka 320 mg film-coated tablets
PA1347/010/009
Valsartan KRKA, d.d., Novo mesto Not marketed
Valsartan Krka 40 mg film-coated tablets
PA1347/010/006
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan Krka 80 mg film-coated tablets
PA1347/010/007
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan Rowa 160 mg film-coated tablets
PA0074/083/003
Valsartan Rowa Pharmaceuticals Limited Not marketed
Valsartan Rowa 320 mg film-coated tablets
PA0074/083/004
Valsartan Rowa Pharmaceuticals Limited Not marketed
Valsartan Rowa 40 mg film-coated tablets
PA0074/083/001
Valsartan Rowa Pharmaceuticals Limited Not marketed
Valsartan Rowa 80 mg film-coated tablets
PA0074/083/002
Valsartan Rowa Pharmaceuticals Limited Not marketed
Valsartan Teva 160 mg Film-coated Tablets
PA0749/084/003
Valsartan Teva Pharma B.V. Marketed
Valsartan Teva 40 mg Film-coated Tablets
PA0749/084/001
Valsartan Teva Pharma B.V. Not marketed
Valsartan Teva 80 mg Film-coated Tablets
PA0749/084/002
Valsartan Teva Pharma B.V. Marketed
Valsartan Viatris 160 mg Film-coated Tablets
PA23266/006/003
Valsartan Viatris Limited Marketed
Valsartan Viatris 320 mg Film-coated Tablets
PA23266/006/004
Valsartan Viatris Limited Marketed
Valsartan Viatris 40 mg Film-coated Tablets
PA23266/006/001
Valsartan Viatris Limited Marketed
Valsartan Viatris 80 mg Film-coated Tablets
PA23266/006/002
Valsartan Viatris Limited Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/12.5 mg film-coated tablets
PA1347/004/002
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/25 mg film-coated tablets
PA1347/004/003
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/12.5 mg film-coated tablets
PA1347/004/004
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/25 mg film-coated tablets
PA1347/004/005
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 80 mg/12.5 mg Film-coated Tablets
PA1347/004/001
Hydrochlorothiazide, Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan/Hydrochlorothiazide Teva 160 mg/12.5 mg Film-coated Tablets
PA0749/047/003
Valsartan, Hydrochlorothiazide Teva Pharma B.V. Marketed
Valsartan/Hydrochlorothiazide Teva 160 mg/25 mg Film-coated tablets
PA0749/047/002
Valsartan, Hydrochlorothiazide Teva Pharma B.V. Marketed
Valsartan/Hydrochlorothiazide Teva 80 mg/12.5 mg Film-coated tablets
PA0749/047/001
Valsartan, Hydrochlorothiazide Teva Pharma B.V. Marketed
Valtan 160 mg film-coated tablets
PA0126/211/003
Valsartan Clonmel Healthcare Ltd Marketed
Valtan 40 mg film-coated tablets
PA0126/211/001
Valsartan Clonmel Healthcare Ltd Marketed
Valtan 80 mg film-coated tablets
PA0126/211/002
Valsartan Clonmel Healthcare Ltd Marketed
Valtan Comp 80mg/12.5mg Film-coated tablets
PA0126/216/001
Valsartan, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Valtrex 250 mg Film-Coated Tablets
PA1077/082/001
Valaciclovir GlaxoSmithKline (Ireland) Limited Marketed
Valtrex 500 mg film-coated tablets
PPA0465/459/001
Valaciclovir PCO Manufacturing Ltd.
Valtrex 500 mg Film-coated tablets
PPA1463/173/001
Valaciclovir IMED Healthcare Ltd.,
Valtrex 500mg Film-coated tablets
PA1077/082/002
Valaciclovir GlaxoSmithKline (Ireland) Limited Marketed
1 2 3 4

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.